APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,559,200 | +37.2% | 72,000 | +2.9% | 0.81% | -12.6% |
| Q3 2022 | $4,781,000 | +6.6% | 70,000 | -29.4% | 0.93% | +0.8% |
| Q2 2022 | $4,484,000 | +121.9% | 99,150 | +149.3% | 0.92% | +75.3% |
| Q1 2022 | $2,021,000 | -64.4% | 39,769 | -66.9% | 0.53% | -66.5% |
| Q4 2021 | $5,674,000 | -9.4% | 120,000 | -36.8% | 1.57% | -12.8% |
| Q3 2021 | $6,262,000 | +183.1% | 190,000 | +442.9% | 1.80% | +195.6% |
| Q2 2021 | $2,212,000 | -18.5% | 35,000 | -61.1% | 0.61% | -26.6% |
| Q3 2020 | $2,715,000 | +153.3% | 90,000 | +157.1% | 0.83% | +99.0% |
| Q4 2019 | $1,072,000 | – | 35,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |